The Pharmaceutical Industry Labor-Management Association is trying to defeat drug-pricing proposals around the US, from statehouses in Nevada, Maryland and Oregon to Congress, reported The New York Times.
The group consists of a coalition that includes major drugmakers like Pfizer and Johnson & Johnson as well as large construction-industry unions.
According to the news source, the group's message aligns closely with the talking points of drug companies that claim that US House Speaker Nancy Pelosi's drug pricing bill would stifle innovation and damage a vital US industry.
Pelosi’s bill would require the federal government to negotiate the prices of insulin and as many as 250 other high-priced drugs on behalf of Medicare, and impose financial penalties if companies failed to comply.
The group has been buying print advertisements in local newspapers, mailing fliers to voters in vulnerable Democratic districts, and hiring former labor officials and well-known union lobbyists to deliver their message, the news source said.
The drug companies who are members either did not respond, or declined to comment, the news source said.
To read more NewsPoints articles, click here.